| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | CN1778794A Method for synthetizing 2-chlorine-5-flumethiazine |
| 05/31/2006 | CN1257889C Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053249 Immunoassay; detecting emission |
| 05/30/2006 | US7053234 Antibacterial agents |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053212 Subtype selectivity; cyclohexanecarboxylic acid (4-hydroxy-benzyl)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amide for example; treating estrogen-related disorders such as sexual disorders, bone disorders; reduction of tamoxifen uterotropic effect |
| 05/30/2006 | US7053109 Aminediols for the treatment of Alzheimer's disease |
| 05/30/2006 | US7053107 Antiproliferative agents, angiogenesis inhibitors for treating cancer, eye disorders, diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis; N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide |
| 05/30/2006 | US7053104 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 05/30/2006 | US7053102 A beta -hydroxylactone replaces the natural alpha -hydroxylactone of camptothecin; for treating colon and breast cancer |
| 05/30/2006 | US7053094 Increasing contractile force in cardiac muscle fiber by administering a N-[(3-yloxy)-phenyl]-arylamide derivatives; modulating at the cardiac sarcomere (cardiac beta myosin) for congestive heart failure |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053020 Catalyst systems for ethylene oligomerisation to linear alpha olefins |
| 05/30/2006 | US7052742 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 05/30/2006 | US7052704 Comprises fatty acid-conjugated products with disulfide linkage to proteins/peptides for delivery to cells; increases absorption and prolongs blood and tissue retention |
| 05/30/2006 | CA2117377C Substituted amino alkyl compounds |
| 05/26/2006 | WO2006055187A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/26/2006 | WO2006054151A1 Synthesis of 5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester |
| 05/26/2006 | WO2005097712A3 Process for preparing diimine compounds |
| 05/26/2006 | CA2585172A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 05/25/2006 | US20060111593 Coupling catalyst and process using the same |
| 05/25/2006 | US20060111532 Chain transfer agents for RAFT polymerization in aqueous media |
| 05/25/2006 | US20060111531 Chain transfer agents for RAFT polymerization in aqueous media |
| 05/25/2006 | US20060111406 Amide linker peroxisome proliferator activated receptor modulators |
| 05/25/2006 | US20060111405 Such as 5,6-diphenylamino-2,3-pyridindione; cyclooxygenase selective inhibitors; antiinflammatory agents |
| 05/25/2006 | US20060111401 Taxanes having a C10 carbonate substituent |
| 05/25/2006 | US20060111344 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/25/2006 | US20060111251 Used as thermooxidation stabilizers for fluorinated lubricating oils and greases; perfluoropolyether with pyridine linking group, and aromatic end groups; prevents corrosion of metals when used with fluorinated lubricating oils |
| 05/25/2006 | US20060110638 Electrochromic compounds |
| 05/24/2006 | EP1659129A1 Coordination metal compound, material for organic electroluminescence device, material for luminescent coating formation and organic electroluminescence device |
| 05/24/2006 | EP1659113A1 Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1) |
| 05/24/2006 | EP1659112A1 Arylpiperazuine derivatives as selective ligand for the dopamine D3 receptor |
| 05/24/2006 | EP1658268A1 Mixtures of ionic liquids with lewis acids |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | EP1658077A2 Dual function compounds and uses thereof |
| 05/24/2006 | EP1575935B1 Process for the preparation of sulphinyl derivatives by oxidation of the corresponding sulfides |
| 05/24/2006 | EP1506185B1 Compounds and their use as inhibitors of 5-ht |
| 05/24/2006 | CN1777663A Organic electroluminescent devices and metal complex compounds |
| 05/24/2006 | CN1777589A Heteroarylcarbamoylbenzene derivative |
| 05/24/2006 | CN1777588A Novel process for the preparation of 2-aminomethylpyridine derivatives |
| 05/24/2006 | CN1777587A Method for the production of nicotinaldehydes |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/24/2006 | CN1775758A 2-chloro-5-pyridyl aldehyde preparing method |
| 05/24/2006 | CN1775757A Pyridyl quinone derivative material and its preparing method |
| 05/24/2006 | CN1775738A Arylamine hole transport material using binaphthalene as backbone and its synthesizing method |
| 05/24/2006 | CN1257160C Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 05/24/2006 | CN1257159C Method for preparing synthetic methyl pyridine |
| 05/24/2006 | CN1257153C Novel propargylether derivatives |
| 05/23/2006 | US7049468 Method for modulating the activity of a Rho C enzyme, comprising: contacting said Rho C enzyme with an effective amount of a compound of formula 1: |
| 05/23/2006 | US7049442 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins |
| 05/23/2006 | US7049378 Polymerization of olefin |
| 05/23/2006 | US7049338 Antiproliferative agents |
| 05/23/2006 | US7049330 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 05/23/2006 | US7049310 Therapy for bacteria infections |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7049271 Herbicides, acaricides, nematicides and insecticides |
| 05/23/2006 | CA2194948C Novel aspartylamide derivatives and sweeteners |
| 05/23/2006 | CA2173747C Calcium receptor-active arylalkyl amines |
| 05/23/2006 | CA2087591C Pyrimidine-3-oxide used for reducing hair loss; topical compositions used therefor |
| 05/18/2006 | WO2006053082A2 Hydroxybenzoate salts of metanicotine compounds |
| 05/18/2006 | WO2006053039A2 Hydroxybenzoate salts of metanicotine compounds |
| 05/18/2006 | WO2006052722A1 Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof |
| 05/18/2006 | WO2006052514A1 Asymmetric hydrogenation of enamides |
| 05/18/2006 | WO2006051810A1 Metal complex compounds and organic electroluminescent devices made by using the same |
| 05/18/2006 | WO2006051808A1 Hsp90 FAMILY PROTEIN INHIBITORS |
| 05/18/2006 | WO2006051704A1 Imine compound |
| 05/18/2006 | WO2006051311A1 Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes |
| 05/18/2006 | WO2006050908A1 Inhibitors of 11βετα-hydroxy steroid dehydrogenase type 1 (11beta-hsd1) |
| 05/18/2006 | WO2006050598A1 Dual antiplatelet/anticoagulant pyridoxine analogs |
| 05/18/2006 | WO2005068074A3 Use of metal complex compounds comprising pyridine pryimidine or s-triazne derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acid and h2o2 |
| 05/18/2006 | WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | US20060106223 Cyanation of aromatic halides |
| 05/18/2006 | US20060106211 Group 9 or 10 metal complexes of N-(N-heterocycle-substuted)acridines, phenoxazines and phenothiazines that are capable of converting a triplet excitation state into light emission and excellent in heat resistance; electronic devices with low power consumption |
| 05/18/2006 | US20060106072 Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors |
| 05/18/2006 | US20060106071 Substituted amides |
| 05/18/2006 | US20060106070 Novel pyridine-based metal chelators as antiviral agents |
| 05/18/2006 | US20060106030 N-(4-(4-(2,3 -dichlorophenyl)piperazin-1-yl)but-2-enyl)-1H-indole-2-carboxamide; imaging agents; tomography;diagnosis/medical/; selective, oral bioavailable drugs; nervous system disorders; central nervous system;oral administration; substance abuse ( cocaine/amphetamine); psychosis; Parkinson's |
| 05/18/2006 | CA2793138A1 Hydroxybenzoate salts of metanicotine compounds |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/18/2006 | CA2586446A1 Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof |
| 05/18/2006 | CA2585490A1 Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes |
| 05/18/2006 | CA2585165A1 Dual antiplatelet/anticoagulant pyridoxine analogs |
| 05/18/2006 | CA2584586A1 Hydroxybenzoate salts of metanicotine compounds |
| 05/18/2006 | CA2584448A1 Hydroxybenzoate salts of metanicotine compounds |
| 05/17/2006 | EP1656405A1 Novel catalysts for selective isocyanate dimerisation |
| 05/17/2006 | EP1656361A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 05/17/2006 | EP1656351A1 Process for preparation of 4-aryl-nicotinamide derivatives |
| 05/17/2006 | EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | EP1656020A2 Pyridinylanilides |
| 05/17/2006 | EP1551821B1 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia |
| 05/17/2006 | EP1516021B1 Printing process using specified azo compounds |
| 05/17/2006 | EP1109787B1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 05/17/2006 | CN1774434A Stable ammonium salts of alpha-liponic acid, the production there of and the use of the same |
| 05/17/2006 | CN1774422A 2,3'-bipyridines derivatives as selective cox-2 inhibitors |
| 05/17/2006 | CN1772737A Synthesis process of chronium 2-picolinate |